Results 261 to 270 of about 590,072 (287)
Some of the next articles are maybe not open access.
Current Opinion in Gastroenterology, 2004
This year the number of papers published regarding hepatocellular carcinoma (HCC) continued to increase compared with last year, coinciding with an increase in incidence and awareness of this tumor.Molecular clock studies determined that hepatitis C-related HCC will continue to increase over the next 20 years mimicking the Japanese epidemic.
Luis J, Lopez, Jorge A, Marrero
+7 more sources
This year the number of papers published regarding hepatocellular carcinoma (HCC) continued to increase compared with last year, coinciding with an increase in incidence and awareness of this tumor.Molecular clock studies determined that hepatitis C-related HCC will continue to increase over the next 20 years mimicking the Japanese epidemic.
Luis J, Lopez, Jorge A, Marrero
+7 more sources
European Journal of Surgical Oncology
An update on the management of Hepatocellular carcinoma (HCC) is provided in the present article for those interested in the UEMS/EBSQ exam in Surgical Oncology. The most recent publications in HCC, including surveillance, guidelines, and indications for liver resection, liver transplantation, and locoregional or systemic therapies, are summarised. The
Cristina Dopazo +7 more
+7 more sources
An update on the management of Hepatocellular carcinoma (HCC) is provided in the present article for those interested in the UEMS/EBSQ exam in Surgical Oncology. The most recent publications in HCC, including surveillance, guidelines, and indications for liver resection, liver transplantation, and locoregional or systemic therapies, are summarised. The
Cristina Dopazo +7 more
+7 more sources
Clinics in Liver Disease, 2006
The number of patients who have hepatocellular carcinoma (HCC) is expected to more than double over the next 1 to 2 decades. Patients who have cirrhosis, regardless of cause, are at the highest risk for developing HCC. This article discusses surveillance of these patients for HCC by alpha-fetoprotein and ultrasound, evaluation using imaging ...
Jorge A, Marrero, Shawn, Pelletier
openaire +2 more sources
The number of patients who have hepatocellular carcinoma (HCC) is expected to more than double over the next 1 to 2 decades. Patients who have cirrhosis, regardless of cause, are at the highest risk for developing HCC. This article discusses surveillance of these patients for HCC by alpha-fetoprotein and ultrasound, evaluation using imaging ...
Jorge A, Marrero, Shawn, Pelletier
openaire +2 more sources
Clinical Journal of Oncology Nursing, 2002
Hepatocellular carcinoma (HCC) is a common malignancy worldwide and is a disease of multifactorial etiology. Strong correlations exist between the prevalence of the hepatitis B and C viruses and HCC incidence. HCC treatment may involve surgical resection, liver transplantation, locoregional treatments, and chemotherapy.
Mary Ann, Huang, Jorge A, Marrero
openaire +4 more sources
Hepatocellular carcinoma (HCC) is a common malignancy worldwide and is a disease of multifactorial etiology. Strong correlations exist between the prevalence of the hepatitis B and C viruses and HCC incidence. HCC treatment may involve surgical resection, liver transplantation, locoregional treatments, and chemotherapy.
Mary Ann, Huang, Jorge A, Marrero
openaire +4 more sources
The Lancet, 1999
Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable.
D F, Schafer, M F, Sorrell
openaire +2 more sources
Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable.
D F, Schafer, M F, Sorrell
openaire +2 more sources
Immunotherapies for hepatocellular carcinoma
Nature Reviews Clinical Oncology, 2021Josep M Llovet +2 more
exaly
New England Journal of Medicine, 2019
Silvestre R, Duran, Robert D B, Jaquiss
openaire +5 more sources
Silvestre R, Duran, Robert D B, Jaquiss
openaire +5 more sources